|
PURPOSE: Donor lymphocyte infusion (DLI) reliably induces durable remission
in 75% to 80% of patients with relapsed chronic myelogenous leukemia (CML)
following allogeneic bone marrow transplantation. We previously reported the
identification of a high titer-specific immunoglobulin G response against two
novel leukemia-associated antigens, CML28 and CML66, which correlated with
immune-induced remission. The present studies characterize _expression_ of CML28
and CML66 in primary hematopoietic tissues.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links
|
